Cargando…
The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
PURPOSE: To evaluate the efficacy of pre-operative intravitreal bevacizumab injection on the rate of postoperative vitreous hemorrhage in patients undergoing vitrectomy for complications of proliferative diabetic retinopathy. METHODS: Consecutive retrospective comparative cohort study. Forty eyes of...
Autores principales: | Al-Kharashi, Abdullah, Galbinur, Tural, Mandelcorn, Efrem D., Muni, Rajeev H., Nabavi, Mir, Kertes, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161812/ https://www.ncbi.nlm.nih.gov/pubmed/28003778 http://dx.doi.org/10.1016/j.sjopt.2016.10.001 |
Ejemplares similares
-
Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008) -
Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment
por: DEHGHANI, Alireza, et al.
Publicado: (2017) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020) -
Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
por: Arevalo, J. Fernando, et al.
Publicado: (2023) -
Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Lopez-Lopez, F., et al.
Publicado: (2012)